Ishita Ayan Dutt, Shivani Shinde, Shine Jacob &Amp;Amp; Sohini Das

Stories by Ishita Ayan Dutt, Shivani Shinde, Shine Jacob &Amp;Amp; Sohini Das

Reality show to apps, Mathrubootham spreads funding wings

Reality show to apps, Mathrubootham spreads funding wings

Rediff.com   25 Sep 2025

Within weeks of announcing his exit as executive chairman of the global software-as-a-service (SaaS) company Freshworks, its founder Girish Mathrubootham appears to be on an investment spree.

A bike with integrated radar and camera-safety systems!

A bike with integrated radar and camera-safety systems!

Rediff.com   24 Sep 2025

Bengaluru-based Ultraviolette launches the fighter jet-inspired X-47 Crossover electric motorcycle at Rs 2.49 lakh, with deliveries to commence in October.

Amazing growth story of the Jindal group

Amazing growth story of the Jindal group

Rediff.com   24 Sep 2025

You have to grow, and grow fast - that's the DNA of the JSW group, chairman Sajjan Jindal said as JSW Cement made its debut on the stock market mid-August. The remark captured not just the moment but also the momentum of JSW's growth story.

When Romance Meets The Rulebook: How Cos Deal With Workplace Relationships

When Romance Meets The Rulebook: How Cos Deal With Workplace Relationships

Rediff.com   24 Sep 2025

Romance may be personal, but when it enters the workplace, particularly in reporting hierarchies, it becomes a matter of governance.

Agnikul Launches India's 1st 3D-Printed Rocket Hub

Agnikul Launches India's 1st 3D-Printed Rocket Hub

Rediff.com   23 Sep 2025

For the first time in India, the facility enables 3D printing of aerospace and rocket components up to one metre in height.

Luxury Cars, Bikes Rev Up For Festival Season

Luxury Cars, Bikes Rev Up For Festival Season

Rediff.com   23 Sep 2025

Luxury carmakers are shifting into high gear with a mix of product launches, personalised experiences and lifestyle-led engagement.

US Tariffs May Drop To 10-15%: CEA

US Tariffs May Drop To 10-15%: CEA

Rediff.com   19 Sep 2025

'I do believe there will be a resolution in the next couple of months on the penal tariff and hopefully on the reciprocal tariff also.'

$282 Billion Indian IT Industry In US Right Wing's Cross Hairs

$282 Billion Indian IT Industry In US Right Wing's Cross Hairs

Rediff.com   17 Sep 2025

The US remains the largest market for IT outsourcing, and for Indian giants TCS, Infosys and Wipro, it contributes around 40 per cent of their top line.

How Gen Z And Social Media Are Changing Nepal

How Gen Z And Social Media Are Changing Nepal

Rediff.com   16 Sep 2025

From mobilising protests to choosing the interim prime minister -- Discord, Bitchat became virtual control rooms, even as familiar platforms like TikTok, Reddit, Instagram, etc. played their part.

Late Engineering Changes Stall 80% of Auto Launches

Late Engineering Changes Stall 80% of Auto Launches

Rediff.com   16 Sep 2025

'The delay is high in India, and even higher in the case of electric vehicles.'

It's time to get started, put money in deals: M&A financing opens up

It's time to get started, put money in deals: M&A financing opens up

Rediff.com   15 Sep 2025

Last fortnight, State Bank of India Chairman C S Setty lifted the veil on a subject long spoken of in corporate corridors: Why can't our banks finance mergers and acquisitions (M&As)? Change is in the air: Indian Banks' Association (of which Setty is the chairman) is to "make a formal request" to Mint Road to make way for it. Thus far the exclusive turf of foreign banks even though its funding remains offshore - as in, it's not on these entities rupee-book (and a few select shadow banks) - a most lucrative segment in the investment banking suite, M&As, will be homeward-bound.

GST Cut: How Much Will States Lose?

GST Cut: How Much Will States Lose?

Rediff.com   15 Sep 2025

Opposition-ruled states warn of steep annual losses; Centre assures higher consumption will offset revenue hit.

Patients to benefit from GST cut, but pharma firms may face margin pressure

Patients to benefit from GST cut, but pharma firms may face margin pressure

Rediff.com   12 Sep 2025

The rationalisation of goods and services tax (GST), announced on Wednesday, directly lowers the cost of everyday medical consumables, and also high-end therapies in oncology and rare diseases, helping reduce out-of-pocket patient expenditure and better adherence to medication.

Helped by GST move, PV sales growth may rebound to 7% by FY27: Maruti

Helped by GST move, PV sales growth may rebound to 7% by FY27: Maruti

Rediff.com   12 Sep 2025

The country's largest carmaker Maruti Suzuki India expects auto sales to bounce back to the glory days of 7 per cent growth by FY 27, helped by the proposed GST rate cut which is expected to bring down car prices by 3.5 to 8.5 per cent.

Rare Earth Magnet Crunch Persists For Automakers

Rare Earth Magnet Crunch Persists For Automakers

Rediff.com   11 Sep 2025

'Despite assurance from China, none of the companies have received supplies from Chinese sellers.'

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com   10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

Indian IT Cos Feel H-1B Heat

Indian IT Cos Feel H-1B Heat

Rediff.com   6 Sep 2025

'It is good to have the H1-B visa option but if tomorrow things happen to change, it is not the end of the world situation.'

'US Is An Important Market For Us'

'US Is An Important Market For Us'

Rediff.com   5 Sep 2025

Businesses are testing new markets, tapping into domestic demand, and pushing the government for relief.

EV Spark Fires Up R&D Spending By Legacy Two-Wheeler Majors

EV Spark Fires Up R&D Spending By Legacy Two-Wheeler Majors

Rediff.com   3 Sep 2025

Hero MotoCorp and TVS Motor crossed Rs 1,000 crore in R&D spend for the first time, as legacy OEMs accelerate innovation to compete with new-age EV players.

Kerala's SMA Treatment Model Offers Hope

Kerala's SMA Treatment Model Offers Hope

Rediff.com   2 Sep 2025

The Kerala model is crucial as SMA patients in India had a long wait for a viable treatment option.